Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02802592 · ClinicalTrials.gov registry record · Phase 1
EPOgen and Restrictive Transfusions in Patients Undergoing Cardiac Surgery (EPORT)
A Phase 1 study, sponsored by Johns Hopkins University.
- Terminated
- Registry status
- Phase 1
- Development phase
- 4
- Enrollment target
NCT02802592: Clinical Trial Phase 1 study, sponsored by Johns Hopkins University.
NCT02802592 is a Phase 1 study that was terminated before completion, run by Johns Hopkins University. The registered enrollment target is 4 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02802592, a Phase 1 study, was terminated before completion, sponsored by Johns Hopkins University.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 4 participants
- Enrollment target
Study Summary
EPOgen and Restrictive Transfusions in Patients Undergoing Cardiac Surgery (EPORT)
Interventions
- DRUG Normal Saline
- DRUG Epogen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2015-05 |
| Est. Completion | 2017-02-27 |
| Phase | Phase 1 |
Why NCT02802592 stopped before completion
NCT02802592 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 2 interventions - of which Normal Saline is the first listed.
NCT02802592 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02802592 about?
NCT02802592 is a clinical study titled "EPOgen and Restrictive Transfusions in Patients Undergoing Cardiac Surgery (EPORT)". EPOgen and Restrictive Transfusions in Patients Undergoing Cardiac Surgery (EPORT)
What is the current status of trial NCT02802592?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 4 participants. The study started on 2015-05. Estimated completion is 2017-02-27.
What interventions are being tested in trial NCT02802592?
The interventions under investigation include: Normal Saline (DRUG), Epogen (DRUG).
Who is sponsoring clinical trial NCT02802592?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02802592's enrollment target sits among peer trials
4 1995th of 2000 higher than 2 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia